B J Druker1. Show Affiliations » 1. Division of Hematology and Medical Oncology, Oregon Health Sciences University, Portland 97201, USA.
Abstract
Mesh： See more » BenzamidesClinical Trials as TopicEnzyme Inhibitors/pharmacologyGene TargetingHumansImatinib MesylateLeukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapyLeukemia, Myelogenous, Chronic, BCR-ABL Positive/geneticsPiperazinesProtein-Tyrosine Kinases/antagonists & inhibitorsProtein-Tyrosine Kinases/geneticsProto-Oncogene Proteins c-kit/drug effectsProto-Oncogene Proteins c-kit/geneticsPyrimidines/pharmacologyPyrimidines/therapeutic use
Substances： See more » BenzamidesEnzyme InhibitorsPiperazinesPyrimidinesImatinib MesylateProtein-Tyrosine KinasesProto-Oncogene Proteins c-kit
Year: 2001 PMID： 11769961 DOI： 10.1016/s0753-3322(01)00137-8
Source DB: PubMed Journal: Biomed Pharmacother ISSN： 0753-3322 Impact factor: 6.529